Canary Capital Files for First US Staked INJ ETF

Canary Capital filed an S-1 with the SEC on July 17, 2025, proposing the first U.S. ETF for staked INJ, the native token of Injective blockchain.

This filing potentially transforms market access to staking rewards, sparking interest in institutional and DeFi sectors, amid notable past crypto ETF trends and regulatory engagements.

Canary’s Staked INJ ETF: A U.S. First

The proposal by Canary Capital introduces the first US exchange-traded fund for staked INJ, providing regulated access to the Injective token. It’s a notable step in bridging the gap between DeFi and traditional finance.

Involved parties include Canary Capital and Injective Labs. Canary has filed the S-1 form with the U.S. SEC. The ETFs aim to attract institutional interest in Injective’s native token, aligning with their broader crypto ETF strategy.

ETF Could Transform Institutional DeFi Investments

The move is likely to influence institutional investment patterns, offering new entry points into DeFi through regulated channels. Market observers have noted high expectations for increased liquidity and traction from such ETF offerings.

Financially, the ETF could direct new investor flows into Injective tokens, spurring interest in its broader blockchain applications. The initiative underscores institutional appetite for DeFi-related assets within compliant frameworks.

Learn from Past Crypto ETF Trends

Previous crypto ETF filings, such as those for Bitcoin and Ethereum, have historically driven significant market activity and adoption. The staked INJ ETF represents a continuation of regulatory acknowledgment for crypto-assets.

Based on these precedents, analysts predict that the ETF filing may enhance Injective’s market visibility, influence price dynamics, and attract diversified investor bases to its DeFi infrastructure.

“History is being made today! Canary Capital just filed the first US Staked $INJ ETF with the SEC, giving institutions and everyday investors a regulated path to access the native Injective token through traditional brokerages and banking rails. Here’s why it’s a big deal 🧵”